Fevertree Drinks' (FEVR) Buy Rating Reaffirmed at Numis Securities
Numis Securities reissued their buy rating on shares of Fevertree Drinks (LON:FEVR – Get Rating) in a research note issued to investors on Thursday, Marketbeat.com reports. The firm currently has a GBX 1,500 ($18.66) price objective on the stock. Several other research firms have also recently commented on FEVR. Jefferies Financial Group reissued a hold […]